Literature DB >> 21593085

Retrograde autologous priming reduces transfusion requirements in coronary artery bypass surgery.

E E Severdija1, J H Heijmans, M Theunissen, J G Maessen, P H Roekaerts, P W Weerwind.   

Abstract

The hypothesis was tested whether retrograde autologous priming (RAP) of the cardiopulmonary bypass system, compared to a standard primed system (NON-RAP group), results in less haemodilution and less transfusion of packed red blood cells. Retrospectively, data was collected from the medical charts of one hundred patients undergoing elective coronary artery bypass grafting using cardiopulmonary bypass. Fifty patients where RAP was used have been compared to fifty patients using NON-RAP. The prime volume in the NON-RAP group was 1,627±108 mL versus 782±96 mL in the RAP group (p<0.001). The lowest haematocrit during perfusion was 22% in the NON-RAP group versus 26% when the RAP technique was used (p<0.001). In the NON-RAP group, 26% of the patients received packed red cells in contrast to 6% in the RAP group (p<0.012). A positive association was found between RAP and less transfusion of packed red blood cells (p<0.012). In conclusion, retrograde autologous priming, reducing the prime volume of the cardiopulmonary bypass system, causes less haemodilution and reduces intraoperative transfusion of packed red blood cells.

Entities:  

Mesh:

Year:  2011        PMID: 21593085     DOI: 10.1177/0267659111408379

Source DB:  PubMed          Journal:  Perfusion        ISSN: 0267-6591            Impact factor:   1.972


  9 in total

1.  The Effect of Standardizing Autologous Prime Techniques in Patients Undergoing Cardiac Surgery with Cardiopulmonary Bypass.

Authors:  Alfred H Stammers; Stephen Francis; Eric A Tesdahl; Randi Miller; Anthony Nostro; Linda B Mongero
Journal:  J Extra Corpor Technol       Date:  2019-12

2.  Lean Flow: Optimizing Cardiopulmonary Bypass Equipment and Flow for Obese Patients-A Technique Article.

Authors:  Joshua M Blessing; Jeffrey B Riley
Journal:  J Extra Corpor Technol       Date:  2017-03

3.  To RAP or Not to RAP: A Retrospective Comparison of the Effects of Retrograde Autologous Priming.

Authors:  Emily Foreman; Morgan Eddy; Jenny Holdcombe; Phoebe Warren; Lisa Gebicke; Pamela Raney; Wilson Clements; James Zellner
Journal:  J Extra Corpor Technol       Date:  2021-12

4.  The effect of retrograde autologous priming volume on haemodilution and transfusion requirements during cardiac surgery.

Authors:  Korneel Vandewiele; Thierry Bové; Filip M J J De Somer; Daniël Dujardin; Martin Vanackere; Dirk De Smet; Annelies T Moerman; Stefaan Bouchez; Katrien François
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-03-12

5.  Comparison of new technology integrated and nonintegrated arterial filters used in cardiopulmonary bypass surgery: a randomized, prospective, and single blind study.

Authors:  Özgür Gürsu; Selim Isbir; Koray Ak; Fethullah Gerin; Sinan Arsan
Journal:  Biomed Res Int       Date:  2013-11-11       Impact factor: 3.411

6.  Positive impact of retrograde autologous priming in adult patients undergoing cardiac surgery: a randomized clinical trial.

Authors:  Britt Hofmann; Claudia Kaufmann; Markus Stiller; Thomas Neitzel; Andreas Wienke; Rolf-Edgar Silber; Hendrik Treede
Journal:  J Cardiothorac Surg       Date:  2018-05-21       Impact factor: 1.637

7.  Effects of Minimal Extracorporeal Circulation on the Systemic Inflammatory Response and the Need for Transfusion after Coronary Bypass Grafting Surgery.

Authors:  Mehmet Emre Elçi; Aydın Kahraman; Emre Mutlu; Cemil Selim İspir
Journal:  Cardiol Res Pract       Date:  2019-06-04       Impact factor: 1.866

8.  Retrograde autologous priming to reduce allogeneic blood transfusion requirements: a systematic review.

Authors:  Nousjka Pa Vranken; Zaheer Ud Babar; Jesse A Montoya; Patrick W Weerwind
Journal:  Perfusion       Date:  2020-02-03       Impact factor: 1.972

9.  Clinical applications of retrograde autologous priming in cardiopulmonary bypass in pediatric cardiac surgery.

Authors:  G W Fu; Y F Nie; Z Y Jiao; W Z Zhao
Journal:  Braz J Med Biol Res       Date:  2016-04-26       Impact factor: 2.590

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.